Trial Details
TERMINATEDBasic Information
| Clinical ID | c1379 |
|---|---|
| Identifier | NCT05130983 |
| Trial Title | Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: ExoFlo |
Participant Information
| Sponsor | Direct Biologics, LLC |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-01-23 |
|---|---|
| Primary Completion Date | 2024-12-01 |
| Completion Date | 2024-12-01 |